-
COVID-19 antibodies prevent reinfection for at least 7 months
Qatar // 28 April, 2021
COVID-19 antibodies may persist for over 7 months...COVID-19
-
Study: ECDC data suggests COVID-19 Variants of Concern are associated with higher risk of hospital and ICU admission
28 April, 2021
Study: Increased risk of hospitalisation and ICU admission with variants of concern...COVID-19
-
WHO COVID-19 Weekly reports, April 2021
28 April, 2021
Summary of WHO weekly reports...COVID-19
-
New study indicating several maternal and neonatal complications with COVID-19
27 April, 2021
Maternal and neonatal complications with COVID-19...COVID-19
-
SARS-CoV-2 Variant Strain “501.V2” detected outside South Africa
Australia // Austria // Belgium // Botswana // Brazil // Canada // China // Cuba // Denmark // Finland // France // Germany // Ghana // Greece // Israel // Ireland // Japan // Kenya // Mayotte // Mozambique // Netherlands // New Zealand // Norway // Panama // South Africa // South Korea // Spain // Switzerland // Sweden // Taiwan (China) // Turkey // United Arab Emirates // United Kingdom // United States // Vietnam // Zambia // India // Philippines // Iran // 27 April, 2021
A variant called 501.V2 first detected in South Africa has been detected in many other countries...COVID-19
-
COVID-19 vaccine Nano Covax completes phase 2 trials
Vietnam // 27 April, 2021
Phase 2 trials completed for Nano Covax...COVID-19
-
WHO Pulse survey reports COVID-19 continues to disrupt essential health services
26 April, 2021
Essential health services still disrupted...COVID-19
-
Vaccine Update - Vaccinations open to all eligible adults as more doses arrive
Palau // 26 April, 2021
Vaccinations have opened up to all eligible adults...COVID-19
-
Blood clot concerns related to the Johnson & Johnson vaccine - Countries recommence use of vaccine after EMA and FDA assessment
United States // Netherlands // South Africa // Greece // Czech Republic // Italy // 23 April, 2021
Czech Republic and Italy commences use of Johnson & Johnson vaccine...COVID-19
-
Lancet commentary on vaccine efficacy
23 April, 2021
In a comment to The Lancet Microbe journal, using Relative Risk Reduction (RRR) to portray vaccine efficacy for COVID-19 vaccines is questionedCOVID-19
-
Infected minks detected at Italian farm
Italy // 23 April, 2021
Italy has reported the first infections of COVID-19 in minks...COVID-19
-
Fake COVID-19 vaccine warnings
Bolivia // China // Colombia // Mexico // Poland // South Africa // 22 April, 2021
Warning of fake COVID-19 vaccines have been issued...COVID-19
-
Preliminary study results suggest mRNA COVID-19 vaccines should be available in pregnancy
22 April, 2021
Preliminary study results for mRNA vaccines in pregnancy are encouraging...COVID-19
-
COVID-19 vaccine received through COVAX
Syria // 22 April, 2021
COVID-19 vaccines have arrived in the country.COVID-19
-
Study: B.1.1.7 variant is 45% more contagious, Pfizer vaccine effective against it
Israel // 22 April, 2021
Israeli study finds B.1.1.7 variant is more contagious and the Pfizer-BioNTech vaccine remains effective against it...COVID-19
-
Study: Infection post vaccination due to variant strains
United States // 22 April, 2021
Two vaccine breakthrough infections were detected in New York...COVID-19
-
"Breakthrough" cases among vaccinated people in Chicago nursing homes
United States // 22 April, 2021
A small number of infections occurred among people who were fully vaccinated....COVID-19
-
Phase 3 vaccine trial of VLA2001 launched in the UK
United Kingdom // 22 April, 2021
Valneva launches Phase 3 vaccine trial of VLA2001...COVID-19
-
ECDC guidance for adjusting non-pharmaceutical interventions based on vaccination status
21 April, 2021
Interim guidance for fully vaccinated individuals published...COVID-19
-
COVID-19 infection in mink farm confirmed
Latvia // 21 April, 2021
The first detection of COVID-19 in minks has been reported...COVID-19